DBV Technologies S.A. Stock News

Shares of DBV TECHNOLOGIE/S (NASDAQ:DBVT) have received a consensus recommendation of “Buy” from the thirteen analysts that are presently covering the stock, Marketbeat.com reports. Four investmen

Montrouge, France, April 30, 2020 DBV Technologies Reports March 31, 2020 Cash Position DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a.

Gainers AgEagle Aerial Systems, Inc. (NASDAQ: UAVS) shares climbed 76.1% to $4.05 after jumping 160% on Wednesday. QEP Resources, Inc. (NYSE: QEP) shares climbed 46.2% to $1.05...

LMP Automotive Holdings (NASDAQ:LMPX) +35%.AgEagle Aerial Systems (NYSEMKT:UAVS) +27%.Soligenix (NASDAQ:SNGX) +25% on positive SGX301 data.Secoo Holding (NASDAQ:SECO) +26% on share repurchase progra

Gainers QEP Resources, Inc. (NYSE: QEP) shares rose 68.5% to $1.21 in pre-market trading after the company reported strong Q1 earnings. AgEagle Aerial Systems, Inc. (NYSE: UAVS)...

Gainers • Chimerix, Inc. (NASDAQ:CMRX) shares increased by 38.41% to $2.09 during Wednesday's pre-market session. • Accuray, Inc. (NASDAQ:ARAY) shares increased by...

The "Global Allergy Immunotherapies Market 2020-2024" report has been added to ResearchAndMarkets.com's offering.

AIMT is currently near its 52-week lows after Palforzia's approval. The bullish view differs with the bearish one on the commercial potentia issue. Here I weigh

Gainers SAExploration Holdings, Inc. (NASDAQ: SAEX) shares surged 98.2% to close at $2.22 on Wednesday after the company disclosed a new project in Greece. The Peck Company...

Montrouge, France, April 20, 2020 DBV Technologies Announces Results of its 2020 Ordinary and Extraordinary General Meeting Shareholders approve all proposed resolutions DBV.

A recent drug approval, a competitor's setback, and a discounted stock price make Aimmune an intriguing investment.